These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 9002771)

  • 1. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
    Celentano L; Sullo P; Klain M; Lupoli G; Cascone E; Salvatore M
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings.
    Adams S; Baum RP; Hertel A; Schumm-Draeger PM; Usadel KH; Hör G
    Eur J Nucl Med; 1998 Sep; 25(9):1277-83. PubMed ID: 9724377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor.
    Rufini V; Salvatori M; Saletnich I; Valenza V; Maussier ML; Martino G; Corsello SM; Pantusa M; Casolo A; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):140-4. PubMed ID: 9002774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
    Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
    Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery.
    Arslan N; Ilgan S; Yuksel D; Serdengecti M; Bulakbasi N; Ugur O; Ozguven MA
    Clin Nucl Med; 2001 Aug; 26(8):683-8. PubMed ID: 11452174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
    Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
    Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors.
    Limouris GS; Giannakopoulos V; Stavraka A; Toubanakis N; Vlahos L
    Anticancer Res; 1997; 17(3B):1589-92. PubMed ID: 9179199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative gamma probe detection of neuroendocrine tumors.
    Adams S; Baum RP; Hertel A; Wenisch HJ; Staib-Sebler E; Herrmann G; Encke A; Hör G
    J Nucl Med; 1998 Jul; 39(7):1155-60. PubMed ID: 9669386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
    Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A
    Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
    Kurtaran A; Scheuba C; Kaserer K; Schima W; Czerny C; Angelberger P; Niederle B; Virgolini I
    J Nucl Med; 1998 Nov; 39(11):1907-9. PubMed ID: 9829581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma: a comparison of preoperative and intraoperative tumor localization with histopathologic findings.
    Adams S; Acker P; Lorenz M; Staib-Sebler E; Hör G
    Cancer; 2001 Jul; 92(2):263-70. PubMed ID: 11466678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medullary carcinoma of the thyroid: management of persistent hypercalcitonaemia utilizing [99mTc] (v) dimercaptosuccinic acid scintigraphy.
    Udelsman R; Mojiminiyi OA; Soper ND; Buley ID; Shepstone BJ; Dudley NE
    Br J Surg; 1989 Dec; 76(12):1278-81. PubMed ID: 2557953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma.
    Berná L; Cabezas R; Mora J; Torres G; Estorch M; Carrió I
    J Endocrinol; 1995 Feb; 144(2):339-45. PubMed ID: 7706986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 111In-octreotide scintigraphy in metastatic medullary thyroid carcinoma before and after octreotide therapy: in vivo evidence of the possible down-regulation of somatostatin receptors.
    Ronga G; Salerno G; Procaccini E; Mauro L; Annovazzi A; Barone R; Mellozzi M; Tamburrano G; Signore A
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):134-6. PubMed ID: 9002772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
    Gómez-Camarero P; Ortiz-de Tena A; Borrego-Dorado I; Vázquez-Albertino RJ; Navarro-González E; Ruiz-Franco-Baux JV; Cuenca-Cuenca JI
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):261-6. PubMed ID: 23067528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor imaging in persistent medullary thyroid carcinoma.
    Frank-Raue K; Bihl H; Dörr U; Buhr H; Ziegler R; Raue F
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):31-7. PubMed ID: 7889629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
    Mucha SA; Kunert-Radek J; Pomorski L
    Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentavalent Tc-99m DMSA accumulation in a medullary carcinoma of the thyroid.
    Hirano T; Otake H; Watanabe N; Oriuchi N; Fukuda T; Endo K
    Clin Nucl Med; 1997 May; 22(5):339-40. PubMed ID: 9152545
    [No Abstract]   [Full Text] [Related]  

  • 19. Somatostatin and somatostatin analogues in medullary thyroid carcinoma.
    O'Byrne KJ; O'Hare N; Sweeney E; Freyne PJ; Cullen MJ
    Nucl Med Commun; 1996 Sep; 17(9):810-6. PubMed ID: 8895910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
    Kosowicz J; Mikołajczak R; Czepczyński R; Ziemnicka K; Gryczyńska M; Sowiński J
    Cancer Biother Radiopharm; 2007 Oct; 22(5):613-28. PubMed ID: 17979564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.